{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:42:07Z","timestamp":1790484127043,"version":"4.1.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7,1]]},"DOI":"10.1093\/cid\/cix288","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T16:02:24Z","timestamp":1490716944000},"page":"107-109","source":"Crossref","is-referenced-by-count":8,"title":["Definitive Treatment for Methicillin-Susceptible Staphylococcus aureus Bacteremia: Data Versus a Definitive Answer?"],"prefix":"10.1093","volume":"65","author":[{"given":"Adolf W","family":"Karchmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,3,31]]},"reference":[{"key":"key\n\t\t\t\t20170920205551_CIT0001","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/CMR.05022-11","article-title":"Predictors of mortality in Staphylococcus aureus bacteremia","volume":"25","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20170920205551_CIT0002","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1469-0691.2006.01589.x","article-title":"Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000","volume":"13","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20170920205551_CIT0003","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1469-0691.2005.01359.x","article-title":"Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre","volume":"12","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20170920205551_CIT0004","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jinf.2009.07.015","article-title":"Mortality of S. aureus bacteremia and infectious diseases specialist consultation\u2014a study of 521 patients in Germany","volume":"59","year":"2009","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20170920205551_CIT0005","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1128\/AAC.8.3.344","article-title":"Effect of inoculum and of beta-lactamase on the anti-staphylococcal activity of thirteen penicillins and cephalosporins","volume":"8","year":"1975","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170920205551_CIT0006","doi-asserted-by":"crossref","first-page":"S386","DOI":"10.1093\/infdis\/128.Supplement_2.S386","article-title":"Clinical experiences with cefazolin and other cephalosporins in bacterial endocarditis","volume":"128","year":"1973","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170920205551_CIT0007","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.1977.03270330059022","article-title":"Unsuccessful treatment of staphylococcal endocarditis with cefazolin","volume":"237","year":"1977","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170920205551_CIT0008","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1086\/379021","article-title":"Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue","volume":"37","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170920205551_CIT0009","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1086\/430833","article-title":"Cefazolin therapy for Staphylococcus aureus bacteremia","volume":"41","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170920205551_CIT0010","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/infdis\/141.3.331","article-title":"Importance of beta-lactamase inactivation in treatment of experimental endocarditis caused by Staphylococcus aureus","volume":"141","year":"1980","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170920205551_CIT0011","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1128\/AAC.13.1.74","article-title":"Treatment of experimental Staphylococcus aureus endocarditis: comparison of cephalothin, cefazolin, and methicillin","volume":"13","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170920205551_CIT0012","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jac\/9.5.387","article-title":"Cefazolin versus cephalothin in beta-lactamase-producing Staphylococcus aureus endocarditis in a rabbit experimental model","volume":"9","year":"1982","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170920205551_CIT0013","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1128\/AAC.37.3.554","article-title":"Relative efficacies of broad-spectrum cephalosporins for treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis","volume":"37","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170920205551_CIT0014","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/infdis\/147.6.1078","article-title":"Staphylococcal beta-lactamase and efficacy of beta-lactam antibiotics: in vitro and in vivo evaluation","volume":"147","year":"1983","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170920205551_CIT0015","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1128\/AAC.00856-13","article-title":"In vivo effects of cefazolin, daptomycin, and nafcillin in experimental endocarditis with a methicillin-susceptible Staphylococcus aureus strain showing an inoculum effect against cefazolin","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170920205551_CIT0016","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.diagmicrobio.2015.07.011","article-title":"The cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus blood isolates: their association with dysfunctional accessory gene regulator (agr)","volume":"83","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170920205551_CIT0017","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1093\/jac\/dkt254","article-title":"Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals","volume":"68","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170920205551_CIT0018","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1128\/AAC.00052-12","article-title":"Prevalence of blaZ gene types and the inoculum effect with cefazolin among bloodstream isolates of methicillin-susceptible Staphylococcus aureus","volume":"56","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170920205551_CIT0019","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/AAC.00317-09","article-title":"Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure","volume":"53","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170920205551_CIT0020","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10096-014-2241-5","article-title":"Prevalence of blaZ gene types and the cefazolin inoculum effect among methicillin-susceptible Staphylococcus aureus blood isolates and their association with multilocus sequence types and clinical outcome","volume":"34","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170920205551_CIT0021","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1089\/mdr.2013.0229","article-title":"Clinical implications of cefazolin inoculum effect and \u03b2-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia","volume":"20","year":"2014","journal-title":"Microb Drug Resist"},{"key":"key\n\t\t\t\t20170920205551_CIT0022","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications","volume":"132","year":"2015","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170920205551_CIT0023","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","article-title":"2015 ESC guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic surgery (EACTS), the European Association of Nuclear Medicine (EANM)","volume":"36","author":"Document Reviewers","year":"2015","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170920205551_CIT0024","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/cid\/ciu301","article-title":"Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting","volume":"59","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170920205551_CIT0025","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1469-0691.2010.03425.x","article-title":"Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?","volume":"17","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20170920205551_CIT0026","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/jac\/dku560","article-title":"Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study","volume":"70","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170920205551_CIT0027","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1128\/AAC.00243-16","article-title":"Cefazolin versus nafcillin for methicillin-sensitive Staphylococcus aureus bloodstream infection in a California tertiary medical center","volume":"60","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170920205551_CIT0028","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1128\/AAC.04677-14","article-title":"Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections","volume":"59","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170920205551_CIT0029","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1128\/AAC.02800-14","article-title":"Comparison of cefazolin versus oxacillin for treatment of complicated bacteremia caused by methicillin-susceptible Staphylococcus aureus","volume":"58","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170920205551_CIT0030","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1128\/AAC.00485-11","article-title":"Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia?","volume":"55","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170920205551_CIT0031","first-page":"XXX","article-title":"Comparative effectiveness of cefazolin versus nafcillin or oxacillin for treatment of methicilin-susceptible Staphylococcus aureus infections complicated by bacteremia: a nationwide cohort study","volume":"XX","year":"2017","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/65\/1\/107\/19982279\/cix288.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T20:56:00Z","timestamp":1505940960000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/65\/1\/107\/3097835\/Definitive-Treatment-for-MethicillinSusceptible"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,31]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,3,31]]},"published-print":{"date-parts":[[2017,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix288","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,31]]}}}